...
首页> 外文期刊>Clinical & developmental immunology. >Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation
【24h】

Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation

机译:I / II型干扰素在HIV-1感染患者中:肠道粘膜和外周血单核细胞中的表达及其在益生菌补充剂上改性

获取原文

摘要

Expression of type I and II interferon (IFN) was evaluated in gut-associated lymphoid tissue (GALT) and peripheral blood mononuclear cells (PBMCs) of HIV-1-positive patients on long-term, suppressive, antiretroviral therapy before and after probiotic supplementation. IFN α subtypes and IFN β were expressed at higher levels in GALT compared to PBMC, whereas an opposite trend of expression was recorded for IFN γ . An increase of IFN α 6, IFN α 10, IFN α 14, IFN α 17, and IFN α 21 and a decrease of IFN γ were observed in both anatomical sites after probiotic supplementation.
机译:在益生菌补充之前和之后,在HIV-1阳性患者的肠道相关淋巴组织(GALT)和外周血单核单核细胞(PBMC)中评估I和II型干扰素(IFN)的表达,益生菌补充剂之前和之后。与PBMC相比,IFNα亚型和IFNβ在GALT的较高水平下表达,而表达的相反趋势被记录为IFNγ。在益生菌补充后,在两个解剖部位观察到IFNα6,IFNα10,IFNα14,IFNα17和IFNα11的增加和IFNγ的降低。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号